Jack Fuchs is an entrepreneur, a lecturer, and an angel investor. His current positions include Board representation, advisor, and CFO responsibilities with IT, med-tech, and clean tech businesses.
From 2012 to 2013, he was CFO of NextBio, Inc., a big-data genomics company targeting personalized medicine, which was acquired by Illumina corporation in October 2013.
Before 2012, Jack was CFO of ForteBio, Inc., a private life science technology company, which was successfully sold to Pall Corporation in March 2012. Previously, he has held leadership positions in Finance, Sales, Marketing, Product Management, and Business Development at a number of private companies, including IPWireless, a 120-person broadband wireless company that was successfully sold to a strategic buyer in 2007. He also sold Lumitrend, a leading wireless applications provider, to Asurion, a device insurance company.
Previously in his career, Jack held several senior positions with Becton Dickinson & Company including Vice President of e-Business, North American Business Leader, Vice President Worldwide Marketing, and Director of Corporate Planning. In addition, Jack was an Engagement Manager with McKinsey & Company, where his client focus was health care and wireless communications.
In addition to his entrepreneurial pursuits, Jack is a Lecturer in Entrepreneurship at Stanford University. Jack mentors entrepreneurs, serves on Boards of private companies, and acts as an angel investor. He holds an AB in Engineering Sciences with Honors from Dartmouth College magna cum laude and phi beta kappa, and he received his MBA from Stanford University as an Arjay Miller Scholar.